Back to Top
Go Back
Journal Photo for Pediatric Hematology and Oncology
Peer reviewed only Open Access

Pediatric Hematology and Oncology (PHO)

Publisher : Taylor & Francis
PHO: Pediatric Hematology and Oncology Treatment in diverse clinical settings Novel insights into pathogenesis and/or clinical care
Claim Your Journal Get PRC Visit Website
e-ISSN 1521-0669
p-ISSN 0888-0018
Issue Frequency 8-issues-year
Impact Factor 1.2
Est. Year 2025
Mobile 4402080520500
DOI YES
Language English
APC YES
Impact Factor Assignee google scholar
Email enquiries@taylorandfrancis.com

Journal Descriptions

PHO: Pediatric Hematology and Oncology is an international journal covering all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. The journal’s goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians, scientists, hematologists, oncologists, and other healthcare professions who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal is interested in basic, clinical, and translational research. Topics of interest include, but are not limited to: Treatment in diverse clinical settings Novel insights into pathogenesis and/or clinical care Genetics Molecular diagnostics and targeting Pharmacology Stem cells Cellular and immune therapies Transplantations Supportive care Ethical, legal, psychological, social, cultural, or historical aspects of the field The journal publishes the following article types Original Research Articles Review Articles Letters to the Editor Brief Reports Meeting Proceedings

Pediatric Hematology and Oncology (PHO) is :-

  • International, Peer-Reviewed, Open Access, Refereed, PHO: Pediatric Hematology and Oncology, Treatment in diverse clinical settings, Novel insights into pathogenesis and/or clinical care, Pharmacology, Stem cells, Original Research Articles, Transplantations , Online or Print , 8-issues-year Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0888-0018, E-ISSN: 1521-0669, Established: 2025, Impact Factor: 1.2
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of PHO

Primary Central Nervous System Burkitt Lymphoma With Non-Immunoglobulin Heavy Chain Translocation in Right Ventricle: Case Report
Li-qun Zou May, 2011
Primary central nervous system Burkitt lymphoma (PCNSBL) is rare. Few cases of primary central nervous system involvement with sporadic Burkitt lymphoma have been reported and its treatment ...
Health-related quality of life and emotional problems in children surviving brain tumor treatment: A descriptive study of 2 cohorts
Arianne B June, 2016
The survival of childhood brain tumors has improved in the past 30 years, but acquired brain injury due to damage caused by tumor invasion and side effects of different treatment modalities ...
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors
Eva Clemens June, 2017
Cisplatin and carboplatin are effective antineoplastic agents. They are also considered to be potentially highly ototoxic. To date, no long-term follow-up data from well-documented cohorts w...
Efficacy of standard prophylaxis versus on-demand treatment with bayer’s sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with s...
Yongqiang Zhao July, 2017
In China, care of patients with severe hemophilia primarily involves insufficient dosing of on-demand treatment and secondary low-dose prophylaxis (10 IU/kg 2× /wk). We sought to evaluate 3...
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors
Kleopatra Georgantzi May, 2018
Chromogranin A (CgA) and neuron specific enolase (NSE) are important markers in adult neuroendocrine tumors (NET). Neuroblastoma (NB) has certain neuroendocrine properties. The aim of this s...
Survival of children with a Wilms tumor in Blantyre, Malawi
Trijn Israels September, 2018
Wilms tumor (WT) has a survival rate above 90% in high income countries. Reported survival rates in sub-Saharan Africa are much lower and long-term outcome is not well known as follow-up is ...
Social competence in newly diagnosed pediatric brain tumor patients
Tessa B. November, 2019
Brain tumors (BTs) are a common pediatric malignancy. Improved treatment has resulted in higher survival rates. There is, however, increasing concern about adverse effects of the disease and...
Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes
Mirjam Vreugdenhil October, 2020
Chronic low-grade inflammation in type 1 diabetes (T1D) might increase hepcidin synthesis, possibly resulting in functional iron deficiency (FID). We hypothesized that in T1D children with F...
Microsatellite instability-high is rare events in refractory pediatric solid tumors
Yoshiyuki Takahashi December, 2021
Microsatellite instability (MSI)-high status is associated with good responsiveness to immune checkpoint inhibitors. Although MSI-high status has been actively investigated in pediatric brai...
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia ...
Yuyang Zhang January, 2022
MicroRNA-199a (miR-199a) inhibits the progression of several hematological malignancies and enhances the sensitivity to chemotherapy in acute myeloid leukemia (AML), but its clinical role in...